Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Ascentage to Begin China Phase III Trial of TKI for SDH-deficient GIST

publication date: Jun 11, 2024

Suzhou Ascentage Pharma was approved to start a China Phase III trial of olverembatinib (HQP1351) as a second-line therapy for succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumor (GIST). Olverembatinib is an orally-available novel third-generation TKI developed by Ascentage Pharma. It its latest trials, olverembatinib achieved a clinical benefit rate of 92.3% in SDH-deficient GIST patients. With a median age of diagnosis of 21 years, the disease is more common in women. It arises primarily in the gastric area with a high propensity to metastasize. More details....

Stock Symbol: (HK: 6855)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here